Clinical Trial Update: Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether albumin provides lasting cognitive improvement in patients with cirrhosis and hepatic encephalopathy, and recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy

Drugs mentioned

• Albumin

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: Cirrhosis, Hepatic Encephalopathy | Phase 2 | Status: RECRUITING